Active ingredientRifabutinCat. No. P-R052-001CAS 72559-06-9Family · Pharmaceutical analytical standards
Rifabutin
An antibiotic of the rifamycin family, discovered in Italy in 1975 and approved in the United States in 1992 to prevent Mycobacterium avium infections in people with HIV; it is also used to treat them and for tuberculosis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It is a semi-synthetic derivative of rifamycin S and, like rifampicin, blocks RNA synthesis in bacteria; it has been included in the WHO list of essential medicines.
Go to the active ingredient →Active ingredientRifabutinCat. No. P-R052-001CAS 72559-06-9
Pharmacopoeial impurityRifabutin EP Impurity ACat. No. P-R052-002CAS 72544-16-2
Pharmacopoeial impurityRifabutin EP Impurity BCat. No. P-R052-003CAS 51756-80-0
Pharmacopoeial impurityRifabutin EP Impurity CCat. No. P-R052-004CAS 2241829-23-0
Pharmacopoeial impurityRifabutin EP Impurity DCat. No. P-R052-005CAS 62041-01-4
Pharmacopoeial impurityRifabutin EP Impurity ECat. No. P-R052-006CAS 100324-63-8
Isotopically labelledRifabutin-d7Cat. No. P-R052-008CAS 2747918-39-2
NitrosamineN-Nitroso RifabutinCat. No. P-R052-009
Impurity25-O-desacetyl-23-Acetyl-RifabutinCat. No. P-R052-010CAS 1242076-43-2
ImpurityRifabutin N-OxideCat. No. P-R052-014CAS 645406-37-7No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceRifabutin CRSEDQM code Y0000149Family RifabutinImpurityRifabutin impurity A CRSEDQM code Y0000184Family RifabutinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.